TY - JOUR
T1 - Bicondylar Tibial Plateau Fractures
T2 - What Predicts Infection?
AU - Olszewski, Nathan
AU - Manzano, Givenchy
AU - Wilson, Eleanor
AU - Joseph, Noah
AU - Vallier, Heather
AU - Pawlak, Amanda
AU - Kottmeier, Stephen
AU - Miller, Adam
AU - Gary, Joshua
AU - Namm, Joshua
AU - Miller, Anna
AU - Gupte, Guarang
AU - Rodriguez-Buitrago, Andre
AU - Obremskey, William
AU - Willier, Donald
AU - Marcantonio, Andrew
AU - Phieffer, Laura
AU - Sheridan, Elizabeth
AU - Li, Katerine
AU - Karunakar, Madhav
AU - Vargas-Hernandez, Juan
AU - Yuan, Brandon
AU - Shapiro, Joshua
AU - Pratson, Lincoln
AU - Friess, Darin
AU - Jenkins, David
AU - Leighton, Ross
AU - Alqudhaya, Rashed
AU - Aljilani, Waael
AU - Mullis, Brian
AU - Gruenwald, Konstantin
AU - Ollivere, Benjamin
AU - Myint, Yulanda
AU - Odom, Christopher
AU - Spitler, Clay
AU - Suwak, Patrik
AU - Shah, Sagar
AU - Rocha, Daniela
AU - Horwitz, Daniel
AU - Tornetta, Paul
N1 - Publisher Copyright:
© American Academy of Orthopaedic Surgeons.
PY - 2022/10/15
Y1 - 2022/10/15
N2 - Objectives:The purpose of this study was to identify the patient, injury, and treatment factors associated with infection of bicondylar plateau fractures and to evaluate whether center variation exists.Design:Retrospective review.Setting:Eighteen academic trauma centers.Patients/participants:A total of 1,287 patients with 1,297 OTA type 41-C bicondylar tibia plateau fractures who underwent open reduction and internal fixation were included. Exclusion criteria were follow-up less than 120 days, insufficient documentation, and definitive treatment only with external fixation.Intervention:Open reduction and internal fixation.Main outcome measurements:Superficial and deep infection.Results:One hundred one patients (7.8%) developed an infection. In multivariate regression analysis, diabetes (DM) (OR [odds ratio] 3.24; P ≤ 0.001), alcohol abuse (EtOH) (OR 1.8; P = 0.040), dual plating (OR 1.8; P ≤ 0.001), and temporary external fixation (OR 2.07; P = 0.013) were associated with infection. In a risk-adjusted model, we found center variation in infection rates (P = 0.030).Discussion:In a large series of patients undergoing open reduction and internal fixation of bicondylar plateau fractures, the infection rate was 7.8%. Infection was associated with DM, EtOH, combined dual plating, and temporary external fixation. Center expertise may also play a role because one center had a statistically lower rate and two trended toward higher rates after adjusting for confounders.Level of evidence:Level IV - Therapeutic retrospective cohort study.
AB - Objectives:The purpose of this study was to identify the patient, injury, and treatment factors associated with infection of bicondylar plateau fractures and to evaluate whether center variation exists.Design:Retrospective review.Setting:Eighteen academic trauma centers.Patients/participants:A total of 1,287 patients with 1,297 OTA type 41-C bicondylar tibia plateau fractures who underwent open reduction and internal fixation were included. Exclusion criteria were follow-up less than 120 days, insufficient documentation, and definitive treatment only with external fixation.Intervention:Open reduction and internal fixation.Main outcome measurements:Superficial and deep infection.Results:One hundred one patients (7.8%) developed an infection. In multivariate regression analysis, diabetes (DM) (OR [odds ratio] 3.24; P ≤ 0.001), alcohol abuse (EtOH) (OR 1.8; P = 0.040), dual plating (OR 1.8; P ≤ 0.001), and temporary external fixation (OR 2.07; P = 0.013) were associated with infection. In a risk-adjusted model, we found center variation in infection rates (P = 0.030).Discussion:In a large series of patients undergoing open reduction and internal fixation of bicondylar plateau fractures, the infection rate was 7.8%. Infection was associated with DM, EtOH, combined dual plating, and temporary external fixation. Center expertise may also play a role because one center had a statistically lower rate and two trended toward higher rates after adjusting for confounders.Level of evidence:Level IV - Therapeutic retrospective cohort study.
UR - http://www.scopus.com/inward/record.url?scp=85139377242&partnerID=8YFLogxK
U2 - 10.5435/JAAOS-D-21-00432
DO - 10.5435/JAAOS-D-21-00432
M3 - Article
C2 - 36200819
AN - SCOPUS:85139377242
SN - 1067-151X
VL - 30
SP - E1311-E1318
JO - Journal of the American Academy of Orthopaedic Surgeons
JF - Journal of the American Academy of Orthopaedic Surgeons
IS - 20
ER -